KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Change in Cash (2016 - 2025)

HCA Healthcare (HCA) has disclosed Change in Cash for 15 consecutive years, with $43.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Cash rose 104.5% to $43.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$893.0 million, a 189.48% decrease, with the full-year FY2025 number at -$893.0 million, down 189.48% from a year prior.
  • Change in Cash was $43.0 million for Q4 2025 at HCA Healthcare, down from $58.0 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $2.1 billion in Q3 2024 to a low of -$1.5 billion in Q2 2022.
  • A 5-year average of -$37.6 million and a median of $24.5 million in 2023 define the central range for Change in Cash.
  • Biggest YoY gain for Change in Cash was 6993.1% in 2024; the steepest drop was 2365.0% in 2024.
  • HCA Healthcare's Change in Cash stood at $424.0 million in 2021, then tumbled by 121.46% to -$91.0 million in 2022, then skyrocketed by 148.35% to $44.0 million in 2023, then plummeted by 2270.45% to -$955.0 million in 2024, then skyrocketed by 104.5% to $43.0 million in 2025.
  • Per Business Quant, the three most recent readings for HCA's Change in Cash are $43.0 million (Q4 2025), $58.0 million (Q3 2025), and -$121.0 million (Q2 2025).